Abstract
There are two IL-15 isoforms and eight isoforms for the IL-15Rα chain whose biological role is poorly understood. Here, we have analysed the intracellular trafficking of IL-15 and IL-15Rα and tried to shed some light on their function(s). In IL-15/GFP CHO transfectants both IL-15 isoforms show nuclear localization. Two melanoma cell lines (MELP and MELREO) spontaneously expressing the IL-15 isoforms, display different intracellular trafficking of the IL-15/IL-15Rα complex. In MELP cells only IL-15Rα is detected inside the nucleus, whereas IL-15 and IL-15Rα assemble at the cell surface and are internalized. Moreover, the transducing molecule TRAF2 co-immunoprecipitates with IL-15Rα and may be deflected to TNFRI using anti-IL-15 blocking mAbs and TNF-α. By contrast, MELREO cells display IL-15Rα and IL-15 nuclear localization but only a partial co-localization of these molecules on the cell surface. In these cells, TRAF2 is strongly associated with IL-15Rα and cannot be deflected by any treatment. Since TRAF2 activates the transcription factor NF-κB, IL-15 through IL-15Rα, could have a role in the control of this pathway. Indeed, anti-IL-15 MaB inhibit the constitutive nuclear localization of NFκB and the phosphorylation of its inhibitor Iκ-Bα. Thus, IL-15Rα controls NF-κB activation, however differences in the intracellular trafficking of the IL-15 and/or IL-15Rα suggest a different biological role for this complex in MELP versus MELREO cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Alleva DG, Kaser SB, Monroy MA, Fenton MJ and Beller DI. . 1997 J. Immunol. 159: 2941–2951.
Anderson DM, Kumaki S, Ahdieh M, Bertles J, Tometsko M, Loomis A, Giri J, Copeland NG, Gilbert DJ, Jenkins NJ, Valentine V, Shapiro DN, Park LS and Cosman D. . 1995 J. Biol. Chem. 270: 29862–29869.
Baldwin Jr AS. . 1996 Annu. Rev. Immunol. 14: 649–681.
Baker SJ and Reddy EP. . 1996 Oncogene 12: 1–9.
Bamford RN, Battiata AP, Burton JD, Sharma H and Waldmann TA. . 1996 Proc. Natl. Acad. Sci. USA 93: 2897–2902.
Barzegar C, Meazza R, Pereno R, Pottin-Clemenceau C, Scudeletti M, Brouty-Boye D, Doucet C, Taoufik Y, Ritz J, Musselli C, Mishal Z, Jasmin C, Indiveri F, Ferrini S and Azzarone B. . 1998 Oncogene 16: 2503–2512.
Bulfone-Paus S, Bulanova E, Pohl T, Budagian V, Durkop H, Ruckert R, Kunzendorf U, Paus R and Krause H. . 1999 FASEB J. 12: 1575–1585.
Dubois S, Magrangeas F, Lehours P, Raher S, Bernard J, Boisteau O, Leroy S, Minvielle S, Godard A and Jacques Y. . 1999 J. Biol. Chem. 38: 26978.
Duffey DC, Chen Z, Dong G, Ondrey FG, Wolf JS, Brown K, Siebenlist U and Van Waes C. . 1999 Cancer Res. 59: 3468–3474.
Gaggero A, Azzarone B, Andrei C, Mishal Z, Meazza R, Zappia E, Rubartelli A and Ferrini S. . 1999 Eur. J. Immunol. 4: 1265.
Ghosh S, May MJ and Kopp EB. . 1998 Annu. Rev. Immunol. 16: 225–260.
Giri JG, Ahdieh M, Eisenman J, Shanebeck K, Grabstein K, Kumaki S, Namen A, Park LS, Cosman D and Anderson D. . 1994 EMBO J. 13: 2822–2830.
Hallahan DE, Virudachalam S, and Kuchibhotla J. . 1998 Cancer Res. 58: 5484–5488.
Meazza R, Gaggero A, Neglia F, Basso S, Sforzini S, Pereno R, Azzarone B and Ferrini S. . 1997 Eur. J. Immunol. 27:: 1049–1054.
Meazza R, Verdiani S, Biassoni R, Coppolecchia M, Gaggero A, Orengo AM, Colombo MP, Azzarone B and Ferrini S. . 1996 Oncogene 12: 2187–2192.
Musso T, Calosso L, Zucca M, Millesimo M, Ravarino D, Giovarelli M, Malavasi F, Ponzi AN, Paus R and Bulfone-Paus S. . 1999 Blood 10: 3531.
Nishimura H, Yajima T, Naiki Y, Tsunobuchi H, Umemura M, Itano K, Matsuguchi T, Suzuki M, Ohashi PS and Yoshikai Y. . 2000 J. Exp. Med. 191: 157.
Shah MH, Hackshaw KV and Caligiuri MA. . 1998 Nat. Med. 4: 643.
Tagaya Y, Kurys G, Thies TA, Losi JM, Azimi N, Hanover JA, Bamford RN and Waldmann TA. . 1997 Proc. Natl. Acad. Sci. USA 94: 14444–14449.
Waldmann TA and Tagaya Y. . 1999 Annu. Rev. Immunol. 17: 19–48.
Washizu J, Nishimura H, Nakamura N, Nimura Y and Yoshikai Y. . 1998 Immunogenetics 48: 1–7.
Acknowledgements
This work was supported by grants from ARC, ANRB (Villejuif, France), AIRC, and MURST. A Gaggero is a recipient of a FIRC fellowship. J Giron-Michel and E Cazes are recipients of an A.R.M.I.A. fellowship.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pereno, R., Giron-Michel, J., Gaggero, A. et al. IL-15/IL-15Rα intracellular trafficking in human melanoma cells and signal transduction through the IL-15Rα. Oncogene 19, 5153–5162 (2000). https://doi.org/10.1038/sj.onc.1203873
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1203873
Keywords
This article is cited by
-
Lung cancer cell-intrinsic IL-15 promotes cell migration and sensitizes murine lung tumors to anti-PD-L1 therapy
Biomarker Research (2024)
-
Tumor cell-expressed IL-15Rα drives antagonistic effects on the progression and immune control of gastric cancer and is epigenetically regulated in EBV-positive gastric cancer
Cellular Oncology (2020)
-
Identification of Relationships Between Interleukin 15 mRNA and Brain-Derived Neurotrophic Factor II mRNA Levels With Formal Components of Temperament in Asthmatic Patients
Molecular Neurobiology (2017)
-
Expression of interleukin-15 and its receptor on the surface of stimulated human umbilical vein endothelial cells
Journal of Huazhong University of Science and Technology [Medical Sciences] (2009)
-
Large intestine intraepithelial lymphocytes from Apc+/+ and Apc+/Min mice and their modulation by indigestible carbohydrates: the IL-15/IL-15R? complex and CD4+CD25+ T cells are the main targets
Cancer Immunology, Immunotherapy (2005)